SUMMARY Forty-one patients with rheumatoid arthritis (RA) maintained on low dose prednisolone (mean 5*8 mg) participated in a double-blind cross-over study to determine the effect of timing (morning or night) of prednisolone dosage on morning stiffness. Prednisolone given at night resulted in a significantly shorter duration of morning stiffness (p=O.OOO1) than did an equivalent dose given in the morning.
In the treatment of RA the amelioration of unacceptable morning stiffness unresponsive to standard clinical measures is an indication for the use of low-dose steroids.' Whether the time at which steroids are taken affects their efficacy or safety is uncertain. In 1958 Di Raimondo and Forsham2 recommended a single morning dose as being safe and effective. Myles and Daly3 and Klinefelter et al. 4 endorsed this view but noted that some RA patients needed a nocturnal dose to control morning stiffness. Kowanko et al. 5 found no difference in pain relief and morning stiffness nor any evidence of hypothalamic-pituitary-adrenal (HPA) axis suppression whatever time of the day low-dose steroids were used; nevertheless they also recommended a was used as a rescue analgesic. The patients were asked to take their study tablets on retiring (10 pm-11 pm) and on rising (6 am-7 am) with milk but not a major meal. The total daily maintenance dose of prednisolone (to the nearest 1 mg) was given as uncoated 1 mg tablets with a similar number of identical placebo tablets. For each patient the study was divided into two one-monthlong phases. In each phase the night dose contained prednisolone during one month and the morning dose during the other month. The sequence of night and morning prednisolone was prearranged according to a randomised schedule and was not revealed to the patient or the observer until the whole study was completed.
The patients were given diaries to make a daily record of: (a) The duration of morning stiffness (MS on a 7-point scale (1=0-15 minutes, 2=15-30 minutes, 3=30-45 minutes, 4=45-60 minutes, 5=60-120 minutes, 6=120-180 minutes and 7= more than 180 minutes). (b) A daily comment of well-being, side-effects, and any change in their joint symptoms.
At the end of the study the patients were also asked to state their preference for the first or second phase of therapy without knowing the sequence of therapy. (Table 3) showed that neither the order of therapy nor within-week therapy gave any significant variation. Because of this homogeneity, a mean score for MS was calculated over each of the four-week therapy 5, periods. Comparison of these means (Table 4) showed significantly less morning stiffness (p=O0OOOl) with night administration. MS scores in the individual patients (Fig. 2) irrespective of the order of administration were shorter in 30 patients (markedly so in 16) on night therapy and seven patients (markedly in two) on morning therapy. Four patients showed no difference in MS between the two phases of the study. The extent of change in MS did not appear to be related (Fig. 3 ) either to the dose or duration of steroid therapy prior to the study. Fig. 3 The effect of dosage and duration ofsteroid therapy prior to the study on the extent ofchange in morning stiffness from morning (am) to night (pm) administration. given has a significant effect on HPA axis suppression. However, there is sufficient evidence that HPA axis suppression is dependent on the type, dose, and duration of steroid therapy. Therefore if efficacy in terms of the relief of morning stiffness is affected by the time at which steroids are given, the use of the drug at the optimal time may permit the smallest possible dose to be used.
In a controlled double-blind trial the results of which were analysed carefully by appropriate statistical methods we, like de Andrade et al.,7 have found that, when low-dose prednisolone is used for the relief of morning stiffness in RA, night time administration is more effective than an equivalent dose given in the morning. Although a majority of our patients were taking prednisolone in the morning prior to the study, there was a significant preference (p<005) for a night dose at the end of the study, suggesting that general wellbeing too may be favourably affected by an evening dose.
Like most Clinics this multiauthor book reflects a diversity of opinions. In this case, within the narrow field dealt with by the book, there is considerable overlap in the material dealt with in the various chapters. The apparent repetition, for instance the aetiology, pathology, and treatment turning up almost everywhere -despite each having chapters of their own -is off-putting at first sight. Yet, in fact, the information within these contributions is different, rarely repetitive, and simply reflects the lack of decisive, consensus views in this field at present. I liked the suggestion that the criteria for classifying cases for prospective studies are different from those needed for immediate clinical management in our current state of ignorance. Nevertheless it is off-putting to find two different overlapping classifications presented in one chapter (and then to find that neither is used in a later chapter on pathology).
There are some oddities and omissions -for instance I would have liked to have seen an in-depth discussion of associated pulmonary disease in polymyositis, which is perhaps a more common clinical problem than cardiac involvement which does merit a separate section. Also odd contributions -such as those on malignancy or on histology -seem tired rewrites, suggesting that a new immunopathological approach might be valuable, as in renal disease. Nevertheless, there is a valuable round up of recent material in most of the reviews. This includes a timely reminder of both old and new aspects of infective myositis together with a very good chapter on its occurrence in immunodeficiency.
I would certainly commend the book to all physicians interested in connective tissue diseases. The interested reader who peruses it from cover to cover will find a good deal of useful information and discover those areas of disagreement which clearly require further study. The quick browser hoping for a dogmatic authoritative statement may be disappointed. This is perhaps a fair comment on the current state of the art in understanding these uncommon but important disorders. 
